MA

Mohit Agarwal

Director Director DIN 09106426
DIN 09106426 First appointment Mar 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohit Agarwal

Data last updated:

Mohit Agarwal was a Director at Margulis And Roemer Pharmaceuticals Private Limited (2025) and Director at Manflame Bio Pharma Private Limited (from 2021). The companies operate in Chemicals.

DIN 09106426
Primary Designation Director
Industry Chemicals
First Appointment 23 Mar 2021
Oldest Company Age 5 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Jan 20252022Active
Manflame Bio Pharma Private Limited U24290DL2021PTC379108
Director23 Mar 20212021Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Manflame Bio Pharma Private Limited
Margulis And Roemer Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mohit Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohit Agarwal

Mohit Agarwal was first appointed on 23 Mar 2021 as Director at Manflame Bio Pharma Private Limited. The most recent appointment on record is 08 Jan 2025 at Margulis And Roemer Pharmaceuticals Private Limited.

Mohit Agarwal held 2 earlier board appointments: Margulis And Roemer Pharmaceuticals Private Limited (Director, 08 Jan 2025 to 21 Jan 2025); Manflame Bio Pharma Private Limited (Director, from 23 Mar 2021).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available